Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stefania Bregante
Observed names:
Bregante,
S Bregante,
S. Bregante
Institution:
Ospedale Policlinico San Martino
Observed institutions:
Azienda Ospedaliera San Gerardo,
National Specialized Hospital for Active Treatment of Hematologic Diseases,
Ospedale Policlinico San Martino
ORCID:
0000-0002-1574-9642
Observed ORCID:
0000-0002-1574-9642
OpenAlex ID:
A5026031351
Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
2012
·
Anna Maria Raiola
, Alida Dominietto
, et al.
·
Transplantation and Cellular Therapy
·
392
PDF
Unmanipulated Haploidentical Transplants Compared with Other Alternative Donors and Matched Sibling Grafts
2014
·
Anna Maria Raiola
, Alida Dominietto
, et al.
·
Transplantation and Cellular Therapy
·
298
PDF
Quality of life in 244 recipients of allogeneic bone marrow transplantation
2000
·
S. Chiodi
, S. Spinelli
, et al.
·
British Journal of Haematology
·
205
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update
2015
·
A Bacigalupo
, A Dominietto
, et al.
·
Bone Marrow Transplantation
·
174
Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft‐versus‐host disease, donor type, cytomegalovirus infections and cell dose
2001
·
Alida Dominietto
, Anna Maria Raiola
, et al.
·
British Journal of Haematology
·
161
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients
2009
·
M Mikulska
, A M Raiola
, et al.
·
Bone Marrow Transplantation
·
156
Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD
2008
·
P Perfetti
, P Carlier
, et al.
·
Bone Marrow Transplantation
·
138
Boost of CD34+-selected peripheral blood cells without further conditioning in patients with poor graft function following allogeneic stem cell transplantation.
2006
·
Alessandra Larocca
, Giovanna Piaggio
, et al.
·
PubMed
·
134
Reducing transplant-related mortality after allogeneic hematopoietic stem cell transplantation.
2004
·
Andrea Bacigalupo
, Maria Pia Sormani
, et al.
·
PubMed
·
104
Factors predicting response and graft-versus-host disease after donor lymphocyte infusions: a study on 593 infusions
2003
·
A M Raiola
, M T Van Lint
, et al.
·
Bone Marrow Transplantation
·
103
CD34 Selected Cells for the Treatment of Poor Graft Function after Allogeneic Stem Cell Transplantation
2014
·
Alessandra Stasia
, Anna Ghiso
, et al.
·
Transplantation and Cellular Therapy
·
97
PDF
Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation
2002
·
Alida Dominietto
, Teresa Lamparelli
, et al.
·
Blood
·
96
PDF
Cytogenetic abnormalities in patients with severe aplastic anemia.
1996
·
N Mikhailova
, M Sessarego
, et al.
·
PubMed
·
93
Donor lymphocyte infusions (DLI) in patients with chronic myeloid leukemia following allogeneic bone marrow transplantation
1997
·
A Bacigalupo
, M Soracco
, et al.
·
Bone Marrow Transplantation
·
84
Leukaemia relapse after allogeneic transplants for acute myeloid leukaemia: predictive role of WT 1 expression
2013
·
Sarah Pozzi
, Simona Geroldi
, et al.
·
British Journal of Haematology
·
74
Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study
1998
·
S Moretti
, P Zikos
, et al.
·
Bone Marrow Transplantation
·
74
DLI after haploidentical BMT with post-transplant CY
2014
·
A Ghiso
, A M Raiola
, et al.
·
Bone Marrow Transplantation
·
73
Bone marrow transplantation for paroxysmal nocturnal hemoglobinuria.
2000
·
A M Raiola
, M T Van Lint
, et al.
·
PubMed
·
73
Combined Foscarnet-ganciclovir Treatment for Cytomegalovirus Infections After Allogeneic Hemopoietic Stem Cell Transplantation1
1996
·
A. Bacigalupo
, S. Bregante
, et al.
·
Transplantation
·
71
Rituximab Treatment for Epstein-Barr Virus DNAemia after Alternative-Donor Hematopoietic Stem Cell Transplantation
2010
·
Stefania Coppoletta
, Elisabetta Tedone
, et al.
·
Transplantation and Cellular Therapy
·
65
PDF
Reduced intensity thiotepa–cyclophosphamide conditioning for allogeneic haemopoietic stem cell transplants (HSCT) in patients up to 60 years of age
2000
·
A. M. Raiola
, M. T. Van Lint
, et al.
·
British Journal of Haematology
·
61
PDF
Thiotepa cyclophosphamide followed by granulocyte colony-stimulating factor mobilized allogeneic peripheral blood cells in adults with advanced leukemia
1996
·
A Bacigalupo
, MT Van Lint
, et al.
·
Blood
·
61
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation
2018
·
Kavita Raj
, Diderik-Jan Eikema
, et al.
·
Transplantation and Cellular Therapy
·
60
PDF
Improved Outcome of Alternative Donor Transplantations in Patients with Myelofibrosis: From Unrelated to Haploidentical Family Donors
2015
·
Stefania Bregante
, Alida Dominietto
, et al.
·
Transplantation and Cellular Therapy
·
58
PDF
Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
1998
·
P Zikos
, M T Van Lint
, et al.
·
PubMed
·
56
Show more works
View as search
Works count:
92
Citation count:
4,072
H-index:
37
I10-index:
59
Year
Topic
Type